{"title":"Educational level and characteristics of invasive breast cancer: findings from a French prospective cohort","authors":"Eloïse Berger, Amandine Gelot, Agnès Fournier, Laure Dossus, Marie-Christine Boutron-Ruault, Gianluca Severi, Raphaële Castagné, Cyrille Delpierre","doi":"10.1007/s10552-024-01873-5","DOIUrl":"https://doi.org/10.1007/s10552-024-01873-5","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Breast cancer (BC) characteristics are known to influence patients survival. Social differences have been reported by previous studies for those characteristics but questions persist because of inconsistent conclusions. We aimed to investigate the impact of education on BC stage, grade, and hormone receptor (HR) status, while adjusting for potential confounders including a broad set of health behaviors, anthropometric measures, and reproductive factors.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>In the French E3N cohort, 5236 women developed a primary invasive BC for which there was available information on stage, grade, and HR status. No multivariate analyses was performed for BC stage based on the lack of association in bivariate analyses. Odds ratios and confidence intervals were estimated using multinomial logistic regression models for BC grade or binomial logistic regression models for HR status of BC.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Women with a lower education were diagnosed with higher grade BC compared to women with a higher education (1.32 [1.12; 1.57]). This association was slightly attenuated after adjustment for covariates independently and more strongly affected in the fully adjusted model (1.20 [0.99; 1.45]). A significant association was observed between lower education and HR- status of BC (1.20 [1.02; 1.42]) attenuated after adjustment for age at first childbirth (1.12 [0.95; 1.33]).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>In this cohort, education was associated with BC grade and HR status but not stage at diagnosis. The link between education and BC grade was not entirely explained by the different adjustments. A specific mechanism could be at play and deserves further investigations.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":"56 1","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140598336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jihwan Hwang, Patricia Markham Risica, Eric Lamy, William Goedel
{"title":"Association between the social vulnerability index and breast, cervical, and colorectal cancer screening rates in Rhode Island","authors":"Jihwan Hwang, Patricia Markham Risica, Eric Lamy, William Goedel","doi":"10.1007/s10552-024-01872-6","DOIUrl":"https://doi.org/10.1007/s10552-024-01872-6","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Cancer screening is effective in reducing the burden of breast, cervical, and colorectal cancers, but not all communities have appropriate access to these services. In this study, we aimed to identify under-resourced communities by assessing the association between the Social Vulnerability Index (SVI) with screening rates for breast, cervical, and colorectal cancers in ZIP-code tabulation areas (ZCTAs) in Rhode Island.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>This study leveraged deidentified health insurance claims data from HealthFacts RI, the state’s all-payer claims database, to calculate screening rates for breast, cervical, and colorectal cancers using Healthcare Effectiveness Data and Information Set measures. We used spatial autoregressive Tobit models to assess the association between the SVI, its four domains, and its 15 component variables with screening rates in 2019, accounting for spatial dependencies.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>In 2019, 73.2, 65.0, and 66.1% of eligible individuals were screened for breast, cervical, and colorectal cancer, respectively. For every 1-unit increase in the SVI, screening rates for breast and colorectal cancer were lower by 0.07% (95% CI 0.01–0.08%) and 0.08% (95% CI 0.02–0.15%), respectively. With higher scores on the SVI’s socioeconomic domain, screening rates for all three types of cancers were lower.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>The SVI, especially its socioeconomic domain, is a useful tool for identifying areas that are under-served by current efforts to expand access to screening for breast, cervical, and colorectal cancer. These areas should be prioritized for new place-based partnerships that address barriers to screening at the individual and community level.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":"56 1","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140598435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dan Lin, Cheryl L. Thompson, Alaina Demalis, Rebecca Derbes, Laila Al-Shaar, Emma S. Spielfogel, Kathleen M. Sturgeon
{"title":"Association between pre-diagnosis recreational physical activity and risk of breast cancer recurrence: the California Teachers Study","authors":"Dan Lin, Cheryl L. Thompson, Alaina Demalis, Rebecca Derbes, Laila Al-Shaar, Emma S. Spielfogel, Kathleen M. Sturgeon","doi":"10.1007/s10552-024-01870-8","DOIUrl":"https://doi.org/10.1007/s10552-024-01870-8","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Studies have reported inverse associations of pre-diagnosis recreational physical activity (RPA) level with all-cause and breast cancer (BCa)-specific mortality among BCa patients. However, the association between pre-diagnosis RPA level and BCa recurrence is unclear. We investigated the association between pre-diagnosis RPA level and risk of BCa recurrence in the California Teachers Study (CTS).</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Stage I–IIIb BCa survivors (<i>n</i> = 6,479) were followed with median of 7.4 years, and 474 BCa recurrence cases were identified. Long-term (from high school to age at baseline questionnaire, or, age 55 years, whichever was younger) and baseline (past 3 years reported at baseline questionnaire) pre-diagnosis RPA levels were converted to metabolic equivalent of task-hours per week (MET-hrs/wk). Multivariable Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for risk of BCa recurrence overall and by estrogen receptor (ER)/progesterone receptor (PR) status.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Long-term RPA was not associated with BCa recurrence risk (<i>p</i><sub>trend</sub> = 0.99). The inverse association between baseline pre-diagnosis RPA level and BCa recurrence risk was marginally significant (≥26.0 vs. <3.4 MET-hrs/wk: HR = 0.79, 95% CI = 0.60–1.03; <i>p</i><sub>trend</sub> = 0.07). However, the association became non-significant after adjusting for post-diagnosis RPA (<i>p</i><sub>trend</sub> = 0.65). An inverse association between baseline pre-diagnosis RPA level and BCa recurrence risk was observed in ER−PR− cases (≥26.0 vs. <3.4 MET-hrs/wk: HR = 0.31, 95% CI = 0.13–0.72; <i>p</i><sub>trend</sub> = 0.04), but not in ER+ or PR+ cases (<i>p</i><sub>trend</sub> = 0.97).</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>Our data indicates that the benefit of baseline RPA on BCa recurrence may differ by tumor characteristics. This information may be particularly important for populations at higher risk of ER−PR− BCa.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":"56 1","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140598605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Erica J. Lee Argov, Carmen B. Rodriguez, Mariangela Agovino, Karen M. Schmitt, Elise Desperito, Anita G. Karr, Ying Wei, Mary Beth Terry, Parisa Tehranifar
{"title":"Screening mammography frequency following dense breast notification among a predominantly Hispanic/Latina screening cohort","authors":"Erica J. Lee Argov, Carmen B. Rodriguez, Mariangela Agovino, Karen M. Schmitt, Elise Desperito, Anita G. Karr, Ying Wei, Mary Beth Terry, Parisa Tehranifar","doi":"10.1007/s10552-024-01871-7","DOIUrl":"https://doi.org/10.1007/s10552-024-01871-7","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Nationally legislated dense breast notification (DBN) informs women of their breast density (BD) and the impact of BD on breast cancer risk and detection, but consequences for screening participation are unclear. We evaluated the association of DBN in New York State (NYS) with subsequent screening mammography in a largely Hispanic/Latina cohort.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Women aged 40–60 were surveyed in their preferred language (33% English, 67% Spanish) during screening mammography from 2016 to 2018. We used clinical BD classification from mammography records from 2013 (NYS DBN enactment) through enrollment (baseline) to create a 6-category variable capturing prior and new DBN receipt (sent only after clinically dense mammograms). We used this variable to compare the number of subsequent mammograms (0, 1, ≥ 2) from 10 to 30 months after baseline using ordinal logistic regression.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>In a sample of 728 women (78% foreign-born, 72% Hispanic, 46% high school education or less), first-time screeners and women who received DBN for the first time after prior non-dense mammograms had significantly fewer screening mammograms within 30 months of baseline (Odds Ratios range: 0.33 (95% Confidence Interval (CI) 0.12–0.85) to 0.38 (95% CI 0.17–0.82)) compared to women with prior mammography but no DBN. There were no differences in subsequent mammogram frequency between women with multiple DBN and those who never received DBN. Findings were consistent across age, language, health literacy, and education groups.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Women receiving their first DBN after previous non-dense mammograms have lower mammography participation within 2.5 years. DBN has limited influence on screening participation of first-time screeners and those with persistent dense mammograms.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":"300 1","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140598345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Investigating the role of county-level colorectal cancer screening rates on stage at diagnosis of colorectal cancer in rural Georgia","authors":"Meng-Han Tsai, Steven S. Coughlin","doi":"10.1007/s10552-024-01874-4","DOIUrl":"https://doi.org/10.1007/s10552-024-01874-4","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>To examine the impact of county-level colorectal cancer (CRC) screening rates on stage at diagnosis of CRC and identify factors associated with stage at diagnosis across different levels of screening rates in rural Georgia.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>We performed a retrospective analysis utilizing data from 2004 to 2010 Surveillance, Epidemiology, and End Results Program. The 2013 United States Department of Agriculture rural–urban continuum codes were used to identify rural Georgia counties. The 2004–2010 National Cancer Institute small area estimates for screening behaviors were applied to link county-level CRC screening rates. Descriptive statistics and multinominal logistic regressions were performed.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Among 4,839 CRC patients, most patients diagnosed with localized CRC lived in low screening areas; however, many diagnosed with regionalized and distant CRC lived in high screening areas (<i>p</i>-value = 0.009). In multivariable analysis, rural patients living in high screening areas were 1.2-fold more likely to be diagnosed at a regionalized and distant stage of CRC (both <i>p</i>-value < 0.05). When examining the factors associated with stage at presentation, Black patients who lived in low screening areas were 36% more likely to be diagnosed with distant diseases compared to White patients (95% CI, 1.08–1.71). Among those living in high screening areas, patients with right-sided CRC were 38% more likely to have regionalized disease (95% CI, 1.09–1.74).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Patients living in high screening areas were more likely to have a later stage of CRC in rural Georgia.</p><h3 data-test=\"abstract-sub-heading\">Impact</h3><p>Allocating CRC screening/treatment resources and improving CRC risk awareness should be prioritized for rural patients in Georgia.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":"71 1","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140598603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jada Roach, Allyson Tabaczynski, William Goodman, Linda Trinh
{"title":"“I have to get up and exercise because that’s how I’m going to get over this”: a qualitative exploration of exercise identity and behavior in early cancer survivorship","authors":"Jada Roach, Allyson Tabaczynski, William Goodman, Linda Trinh","doi":"10.1007/s10552-024-01875-3","DOIUrl":"https://doi.org/10.1007/s10552-024-01875-3","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Exercise is beneficial for people living with and beyond cancer (LWBC); however, many people LWBC fail to meet the exercise guidelines. Having an identity related to exercise, a component of one’s self-concept, correlates with exercising more frequently in general adult populations. Understanding how exercise identity influences exercise behaviors in people LWBC is warranted due to the many barriers people LWBC face in relation to physical activity. The purpose of this study was to explore the perceived impact of an exercise identity of the exercise behaviors and motivations among people LWBC.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Thirteen participants of mixed diagnoses (M<sub>age</sub> = 60.8 ± 10.8 years) in the early survivorship period (i.e., within five years of primary treatment completion or diagnosis) participated in semi-structured interviews to identify influences of exercise identity on exercise behavior. Interviews were transcribed verbatim and analyzed using thematic analysis.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Findings demonstrated that people LWBC with a strong exercise identity engage in high and varied exercise behaviors. Despite barriers such as changes in motivations and ability to engage in exercise, participants maintained exercise throughout cancer by constant adaptation of their outlook and behaviors related to exercise. These results demonstrate a maintenance of physical activity in relation to a strong exercise identity.</p><p><b>Implications for cancer survivors:</b> Results of this study have implications for the design and implementation of exercise behavior change programs for people LWBC as it provides insights into predictors of sustained exercise behavior during and following cancer treatment.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":"5 1","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140598419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Camilla Sköld, Sara Corvigno, Hanna Dahlstrand, Gunilla Enblad, Artur Mezheyeuski, Inger Sundström-Poromaa, Karin Stålberg, Anna Tolf, Ingrid Glimelius, Anthoula Koliadi
{"title":"Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer","authors":"Camilla Sköld, Sara Corvigno, Hanna Dahlstrand, Gunilla Enblad, Artur Mezheyeuski, Inger Sundström-Poromaa, Karin Stålberg, Anna Tolf, Ingrid Glimelius, Anthoula Koliadi","doi":"10.1007/s10552-024-01876-2","DOIUrl":"https://doi.org/10.1007/s10552-024-01876-2","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>High-grade serous ovarian cancer (HGSC) is the most common ovarian cancer subtype. Parity is an important risk-reducing factor, but the underlying mechanism behind the protective effect is unclear. Our aim was to study if the expression of hormones and proteins involved in pregnancy were affected by the woman’s parity status, and if they may be associated with tumor stage and survival.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>We evaluated expression of progesterone receptor (PR), progesterone receptor membrane component 1 (PGRMC1), relaxin-2, and transforming growth factor beta 1 (TGFβ1) in tumor tissue from 92 women with HGSC parous (<i>n</i> = 73) and nulliparous (<i>n</i> = 19). Key findings were then evaluated in an independent expansion cohort of 49 patients. Survival rates by hormone/protein expression were illustrated using the Kaplan–Meier method. The independent prognostic value was tested by Cox regression, using models adjusted for established poor-prognostic factors (age at diagnosis, FIGO stage, type of surgery, and macroscopic residual tumor after surgery).</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>HGSC tumors from parous women were PR positive (≥ 1% PR expression in tumor cells) more often than tumors from nulliparous women (42% vs. 16%; <i>p</i>-value 0.04), and having more children was associated with developing PR positive tumors [i.e., ≥ 3 children versus nulliparity, adjusted for age at diagnosis and stage: OR 4.31 (95% CI 1.12–19.69)]. A similar result was seen in the expansion cohort. Parity status had no impact on expression of PGRMC1, relaxin-2 and TGFβ1. No associations were seen with tumor stage or survival.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Tumors from parous women with HGSC expressed PR more often than tumors from nulliparous women, indicating that pregnancies might possibly have a long-lasting impact on ovarian cancer development.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":"24 1","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140598684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cancer Causes & ControlPub Date : 2024-04-01Epub Date: 2023-11-09DOI: 10.1007/s10552-023-01814-8
Kate Cartwright, Deborah Kanda, Mikaela Kosich, Judith Sheche, Samantha Leekity, Nicholas Edwardson, V Shane Pankratz, Shiraz I Mishra
{"title":"Breast cancer screening attitudes, beliefs, and behaviors of Zuni Pueblo women: identifying cornerstones for building effective mammogram screening intervention programs.","authors":"Kate Cartwright, Deborah Kanda, Mikaela Kosich, Judith Sheche, Samantha Leekity, Nicholas Edwardson, V Shane Pankratz, Shiraz I Mishra","doi":"10.1007/s10552-023-01814-8","DOIUrl":"10.1007/s10552-023-01814-8","url":null,"abstract":"<p><strong>Purpose: </strong>Breast cancer is the leading form of cancer and has the second highest mortality rate of cancers for American Indian/Alaska Native (AI/AN) women. Early screening is critical. This study examines the breast cancer-related knowledge, beliefs, and behaviors of Zuni women in the Southwest United States (U.S.).</p><p><strong>Methods: </strong>In 2020 and 2021, a survey was administered to better understand cancer screening patterns in Zuni Pueblo; 110 women from 50 to 75 years of age were recruited to respond to the breast cancer screening portion. Inclusion criteria included self-identifying as AI, a member of the Zuni tribe, or married to a Zuni tribal member, and meeting the age and gender requirements. Descriptive statistics and bivariate analyses were conducted examining the associations between measures of breast cancer knowledge, beliefs, and behaviors and breast cancer screening status (never, ever/non-compliant, and ever/compliant).</p><p><strong>Results: </strong>Of survey participants, 47.3% have had a breast cancer screening and are up-to-date, 39.1% have had a screening in the past but are not up-to-date, and 13.6% have never been screened. Age was the only statistically significant socioeconomic predictor of breast cancer screening; the median (interquartile range) ages of each group are 62 (54, 68) ever/compliant, 56 (54, 68) ever/non-compliant, and 53 (51, 55) never (p-value < 0.001). Significant differences by health status and access to medical care include having a regular health care provider and going to see a provider for routine check-ups. The survey also shows differences in knowledge about breast cancer risk factors, beliefs, and behaviors. Women across all three screening statuses reported that they would get screened if encouraged by a health care provider.</p><p><strong>Conclusion: </strong>While survey respondents report a relatively high rate of ever having had a breast cancer screening, less than half are compliant with screening guidelines, which shows there is an opportunity to improve breast cancer screening rates. With culturally tailored interventions, providers have the potential to improve breast cancer screening for Zuni women.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":"583-595"},"PeriodicalIF":2.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10960741/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71520595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cancer Causes & ControlPub Date : 2024-04-01Epub Date: 2023-11-28DOI: 10.1007/s10552-023-01825-5
Aditya K Ghosh, Sheena Bhushan, Oluseyi Abidoye, Shane S Robinson, Ania Izabela Rynarzewska, Devi Sampat
{"title":"Evaluating implementation of NCCN guideline-directed genetic screening recommendations for patients with pancreatic ductal adenocarcinoma.","authors":"Aditya K Ghosh, Sheena Bhushan, Oluseyi Abidoye, Shane S Robinson, Ania Izabela Rynarzewska, Devi Sampat","doi":"10.1007/s10552-023-01825-5","DOIUrl":"10.1007/s10552-023-01825-5","url":null,"abstract":"<p><strong>Purpose: </strong>In 2019, the National Comprehensive Cancer Network (NCCN) recommended genetic testing for all patients with pancreatic ductal adenocarcinoma (PDAC). To evaluate the status of implementation of these guidelines in a loco-regional setting, we performed a retrospective, observational study among patients with newly diagnosed PDAC who received oncologic care at Northeast Georgia Medical Center in Georgia.</p><p><strong>Methods: </strong>Chart abstraction of patients with newly diagnosed PDAC from 1 January 2020 to 31 December 2021 was performed to include information on genetic testing recommendation and completion, and time from diagnosis to testing. The deidentified dataset was then analyzed using appropriate descriptive and associative statistical testing.</p><p><strong>Results: </strong>Of the cohort of 109 patients, 32 (29.4%) completed genetic screening; 16 (14.7%) were screened within 10 days of diagnosis. Among the 77 (70.6%) patients who did not receive genetic screening, 45 (41.3%) were not recommended genetic screening despite treatment intent with standard of care therapy. However, 32 (29.4%) were not recommended genetic screening in conjunction with a desire to pursue palliative care/hospice/or due to terminal illness.</p><p><strong>Conclusions: </strong>The study highlighted the gap in implementation of NCCN guideline-directed genetic testing in PDAC patients as only a third underwent testing suggesting the need for systematic processes to facilitate testing. The test was more likely to be completed if done early in the course, especially soon after the diagnosis. Research is needed to explore discussing genetic testing for the large proportion of patients who are terminally ill at diagnosis where genetic screening would potentially benefit the family members.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":"679-684"},"PeriodicalIF":2.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138443975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cancer Causes & ControlPub Date : 2024-04-01Epub Date: 2023-11-29DOI: 10.1007/s10552-023-01827-3
Rachel R Codden, Carol Sweeney, Blessing S Ofori-Atta, Kimberly A Herget, Kacey Wigren, Sandra Edwards, Marjorie E Carter, Rachel D McCarty, Mia Hashibe, Jennifer A Doherty, Morgan M Millar
{"title":"Accuracy of patient race and ethnicity data in a central cancer registry.","authors":"Rachel R Codden, Carol Sweeney, Blessing S Ofori-Atta, Kimberly A Herget, Kacey Wigren, Sandra Edwards, Marjorie E Carter, Rachel D McCarty, Mia Hashibe, Jennifer A Doherty, Morgan M Millar","doi":"10.1007/s10552-023-01827-3","DOIUrl":"10.1007/s10552-023-01827-3","url":null,"abstract":"<p><strong>Purpose: </strong>Race and Hispanic ethnicity data can be challenging for central cancer registries to collect. We evaluated the accuracy of the race and Hispanic ethnicity variables collected by the Utah Cancer Registry compared to self-report.</p><p><strong>Methods: </strong>Participants were 3,162 cancer survivors who completed questionnaires administered in 2015-2022 by the Utah Cancer Registry. Each survey included separate questions collecting race and Hispanic ethnicity, respectively. Registry-collected race and Hispanic ethnicity were compared to self-reported values for the same individuals. We calculated sensitivity and specificity for each race category and Hispanic ethnicity separately.</p><p><strong>Results: </strong>Survey participants included 323 (10.2%) survivors identifying as Hispanic, a lower proportion Hispanic than the 12.1% in the registry Hispanic variable (sensitivity 88.2%, specificity 96.5%). For race, 43 participants (1.4%) self-identified as American Indian or Alaska Native (AIAN), 32 (1.0%) as Asian, 23 (0.7%) as Black or African American, 16 (0.5%) Pacific Islander (PI), and 2994 (94.7%) as White. The registry race variable classified a smaller proportion of survivors as members of each of these race groups except White. Sensitivity for classification of race as AIAN was 9.3%, Asian 40.6%, Black 60.9%, PI 25.0%, and specificity for each of these groups was > 99%. Sensitivity and specificity for White were 98.8% and 47.4%.</p><p><strong>Conclusion: </strong>Cancer registry race and Hispanic ethnicity data often did not match the individual's self-identification. Of particular concern is the high proportion of AIAN individuals whose race is misclassified. Continued attention should be directed to the accurate capture of race and ethnicity data by hospitals.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":"685-694"},"PeriodicalIF":2.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10960663/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138450882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}